Back to Rankings

GPCR

Structure TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
GPCR vs peer average
15/100
GPCR vs. peer average (F vs. B)
Grade spread
A 1 · B 5 · C 4 · D 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ALNY is the first available peer comparator.

Mid-stage biotech with multiple partnered assets — comparable on partnership/de-risking trajectory.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerALNYAlnylam
GPCR
Structure Therapeutics
ALNY
Alnylam
Grade
F
B
Momentum
7
19
Value
41
58
Sentiment
38
95
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ALNY

GPCR / ALNY
Grade Position
Below peers
GPCR vs. peer average (F vs. B)
15/100
Momentum
7
ALNY
Value
41
ALNY
Sentiment
38
ALNY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GPCR
1
ALNY
ALNY
B
80/100
-3
2
IONQ
IONQ
C
60/100
-2
3
MRNA
MRNA
D
40/100
-1
4
RLAY
Relay Therapeutics Inc Common
C
60/100
-2
5
IRON
Disc Medicine Inc Common
C
60/100
-2
ALNY is the first peer returned for this comparison set.